1.
Remacha AF, Arrizabalaga B, Bueno J, Muñoz J, Bargay J, Pedro C. Treatment with mycophenolate mofetil followed by recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes resistant to erythropoietin treatment. Haematologica [Internet]. 2010Feb.5 [cited 2026Nov.13];95(2):339-40. Available from: https://haematologica.org/article/view/5509